Patients who had stopped their aspirin therapy had a two-fold increase in the risk of dying or suffering a myocardial infarction after 1 month, compared to those who continued their aspirin therapy.
Aquellos pacientes que habían suspendido la terapia con aspirina tuvieron un incremento de 2 veces el riesgo de muerte o infarto de miocardio a 1 mes, comparados con los pacientes que continuaron en la terapia con aspirina.